REGISTERED NUMBER: 10389887 (England and Wales)

Unaudited Financial Statements for the Year Ended 30th September 2025

for

JRC Medical Limited

Page

Balance Sheet

1

Notes to the Financial Statements

2

FIXED ASSETS

Tangible assets

4

10,426

19,201

CURRENT ASSETS

Debtors

5

200,863

208,484

Cash at bank

97,483

40,963

298,346

249,447

CREDITORS

Amounts falling due within one year

6

35,755

33,936

NET CURRENT ASSETS

262,591

215,511

TOTAL ASSETS LESS CURRENT LIABILITIES

273,017

234,712

PROVISIONS FOR LIABILITIES

1,981

3,706

NET ASSETS

271,036

231,006

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

270,936

230,906

SHAREHOLDERS' FUNDS

271,036

231,006

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26th May 2026 and were signed on its behalf by:

Dr J R Coakes - Director

1.	COMPANY INFORMATION

JRC Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

10389887

Registered office:

The Lexicon

Mount Street

Manchester

M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its

estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation,

net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values

over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost

Motor Vehicles - 20% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale

proceeds and the carrying value of the asset and is credited or charged to the profit or loss.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

fittings

vehicles

Totals

£

£

£

COST

At 1st October 2024

5,926

47,990

53,916

Additions

1,846

-

1,846

Disposals

(1,765

)

-

(1,765

)

At 30th September 2025

6,007

47,990

53,997

DEPRECIATION

At 1st October 2024

4,321

30,394

34,715

Charge for year

1,023

9,598

10,621

Eliminated on disposal

(1,765

)

-

(1,765

)

At 30th September 2025

3,579

39,992

43,571

NET BOOK VALUE

At 30th September 2025

2,428

7,998

10,426

At 30th September 2024

1,605

17,596

19,201

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Other Debtors consists of a loan between the company and Coakes Property Ltd. This loan is interest free with no set terms of repayment.

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.9.25

30.9.24

£

£

Hire purchase contracts

-

2,455

Corporation tax payable

30,738

27,541

Directors' current accounts

2,644

1,788

Accrued expenses

2,373

2,152

35,755

33,936

The net obligation under finance leases and hire purchases contracts are secured against the assets to which they relate - Motor vehicles

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.9.25

30.9.24

value:

£

£

60

Ordinary A

1

60

60

40

Ordinary B

1

40

40

100

100

The Ordinary A shares rank equally in terms of voting rights and rights to participate in all approved dividend distribution for that class.

The Ordinary B shares rank equally in terms of voting rights and rights to participate in all approved dividend distribution for that class.

The Ordinary A and Ordinary B shares rank pari passu in respect of capital distribution rights.

8.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30th September 2025 and 30th September 2024:

30.9.25

30.9.24

£

£

Dr J R Coakes

Balance outstanding at start of year

(1,788

)

(1,640

)

Amounts advanced

45,788

26,640

Amounts repaid

(46,644

)

(26,788

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(2,644

)

(1,788

)

The loan is repayable on demand and no interest was charged during the year.

9.

CONTROL